Bayer HealthCare

Perspective on Innovation 2006

| 1 - 4 |

1525 KB

Measurement of the coagulation time for a Factor-Xa-Inhibitor assay in the Institute of Cardiovascular Research at the Bayer HealthCare’s Pharmaceuticals Division, Wuppertal, Germany.
1115 KB

Cross-sectional view of a blood vessel: after intravenous injection, Vasovist® (blue) binds reversibly to human serum albumin (green) in plasma, thus providing an extended imaging time window.
905 KB

MR-angiogram of pedal vessels after administration of the blood pool agent Vasovist®. Both arteries and veins can be seen in great detail.
1845 KB

During magnetic resonance imaging (MRI), the patient lies on a table which moves through the MRI machine. This diagnostic procedure uses the magnetic properties of hydrogen atoms in the human body.

| 1 - 4 |

top

Search

Advanced Search

Publications

Stockholders' Newsletter

Annual Report 2007

Sustainable Development Report 2007

research – The Bayer Scientific Magazine

Publications Overview

Newsletter

We will keep you informed about the latest news.

Events

Friday, December 12, 2008

Bayer's Perspective on Innovation 2008

Contact: Katharina Jansen

Additional Press Events

Investor Relations Events

Download Center - Selection

Your selection:
0
Download(s)